Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,694
datasets available to search
ShareScore release 0.9.0
Dataset results
10,694 results for “carcinoma,”
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
ClinicalTrials.gov study NCT02578641. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
ClinicalTrials.gov study NCT01180959. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02513199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00369512. IPD Sharing: Not stated. Countries: 1. Publications: 1.
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT04150900. IPD Sharing: NO. Countries: 1. Publications: 33.
Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases
ClinicalTrials.gov study NCT01505166. IPD Sharing: Not stated. Countries: 1. Publications: 7.
FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07314372. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib
ClinicalTrials.gov study NCT01908426. IPD Sharing: Not stated. Countries: 19. Publications: 6.
Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04401800. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
ClinicalTrials.gov study NCT02450331. IPD Sharing: Not stated. Countries: 24. Publications: 2.
Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder
ClinicalTrials.gov study NCT00706641. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
ClinicalTrials.gov study NCT03040999. IPD Sharing: YES. Countries: 21. Publications: 2.
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
ClinicalTrials.gov study NCT03173560. IPD Sharing: NO. Countries: 16. Publications: 1.
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
ClinicalTrials.gov study NCT03142334. IPD Sharing: YES. Countries: 21. Publications: 5.
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
ClinicalTrials.gov study NCT01581840. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT01621880. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
ClinicalTrials.gov study NCT00631371. IPD Sharing: Not stated. Countries: 30. Publications: 4.
Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma
ClinicalTrials.gov study NCT00059787. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
ClinicalTrials.gov study NCT04869137. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT00903175. IPD Sharing: Not stated. Countries: 19. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.